Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TLC domain-containing protein 5 (TLCD5) is a protein encoded by the TLCD5 gene in humans, predicted to be a membrane-associated protein containing a TLC domain (TRAM, Lag1, and CLN8 domain) family feature. TLCD5 has several transcript variants and orthologues in other species. Current evidence links mutations in TLCD5 to rare conditions such as Combined Oxidative Phosphorylation Deficiency 8 and immature cataract, but its specific biological functions remain largely unknown and it is not considered a therapeutic target or receptor class protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TLC domain-containing protein 5 (TLCD5).